NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness July 13, 2026
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner July 9, 2026
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection June 22, 2026